Janine K Cataldo1, Anne Berit Petersen2, Mary Hunter2, Julie Wang3, Nicolas Sheon4. 1. University of California, San Francisco School of Nursing, San Francisco, CA, USA. janine.cataldo@ucsf.edu. 2. University of California, San Francisco School of Nursing, San Francisco, CA, USA. 3. University of California, San Francisco, Center of Tobacco Control, Research, and Education, San Francisco, CA, USA. 4. San Francisco, Department of Medicine, San Francisco, CA, USA.
Abstract
OBJECTIVES: To describe older smokers' perceptions of risks and use of e-cigarettes, and their responses to marketing and knowledge of, and opinions about, regulation of e-cigarettes. METHODS: Eight 90-minute focus groups with 8 to 9 participants met in urban and suburban California to discuss topics related to cigarettes and alternative tobacco products. RESULTS: Older adults are using e-cigarettes for cessation and as a way to circumvent no-smoking policies; they have false perceptions about the effectiveness and safety of e-cigarettes. They perceive e-cigarette marketing as a way to renormalize smoking. CONCLUSIONS: To stem the current epidemic of nicotine addiction, the FDA must take immediate action because e-cigarette advertising promotes dual use and may contribute to the renormalization of smoking.
OBJECTIVES: To describe older smokers' perceptions of risks and use of e-cigarettes, and their responses to marketing and knowledge of, and opinions about, regulation of e-cigarettes. METHODS: Eight 90-minute focus groups with 8 to 9participants met in urban and suburban California to discuss topics related to cigarettes and alternative tobacco products. RESULTS: Older adults are using e-cigarettes for cessation and as a way to circumvent no-smoking policies; they have false perceptions about the effectiveness and safety of e-cigarettes. They perceive e-cigarette marketing as a way to renormalize smoking. CONCLUSIONS: To stem the current epidemic of nicotine addiction, the FDA must take immediate action because e-cigarette advertising promotes dual use and may contribute to the renormalization of smoking.
Authors: James M Nonnemaker; Jane A Allen; Kevin C Davis; Kian Kamyab; Jennifer C Duke; Matthew C Farrelly Journal: PLoS One Date: 2014-07-17 Impact factor: 3.240
Authors: Jessica L King; David Reboussin; Jennifer Cornacchione Ross; Kimberly D Wiseman; Kimberly G Wagoner; Erin L Sutfin Journal: J Adolesc Health Date: 2018-08-13 Impact factor: 5.012
Authors: Ban A Majeed; Scott R Weaver; Kyle R Gregory; Carrie F Whitney; Paul Slovic; Terry F Pechacek; Michael P Eriksen Journal: Am J Prev Med Date: 2016-10-26 Impact factor: 5.043
Authors: Lauren Collins; Allison M Glasser; Haneen Abudayyeh; Jennifer L Pearson; Andrea C Villanti Journal: Nicotine Tob Res Date: 2019-01-01 Impact factor: 4.244
Authors: Emara Nabi-Burza; Susan Regan; Bethany Hipple Walters; Jeremy E Drehmer; Nancy A Rigotti; Deborah J Ossip; Julie A Gorzkowski; Douglas E Levy; Jonathan P Winickoff Journal: Acad Pediatr Date: 2019-04-11 Impact factor: 3.107
Authors: Allison M Glasser; Lauren Collins; Jennifer L Pearson; Haneen Abudayyeh; Raymond S Niaura; David B Abrams; Andrea C Villanti Journal: Am J Prev Med Date: 2016-11-30 Impact factor: 5.043
Authors: Hanan Qasim; Zubair A Karim; Jose O Rivera; Fadi T Khasawneh; Fatima Z Alshbool Journal: J Am Heart Assoc Date: 2017-08-30 Impact factor: 5.501